Comment
doi: 10.1002/ejhf.2690.
Epub 2022 Sep 28.
Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'
Affiliations
- PMID: 36114731
- DOI: 10.1002/ejhf.2690
Item in Clipboard
Comment
Reply to 'Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease'
Eur J Heart Fail.
2022 Oct.
Free article
No abstract available
Comment on
-
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial.Eur J Heart Fail. 2022 Jul;24(7):1239-1248. doi: 10.1002/ejhf.2527. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35596935 Free PMC article. Clinical Trial.
-
Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease. Letter regarding the article 'Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial'.Eur J Heart Fail. 2022 Oct;24(10):1990. doi: 10.1002/ejhf.2622. Epub 2022 Aug 2. Eur J Heart Fail. 2022. PMID: 35853842 No abstract available.
